Analgesics
Antiandrogens
Antihistamines
Budesonide
Colchicine
Conv. Plasma
Curcumin
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Monoclonals
Mpro inhibitors
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Quercetin
RdRp inhibitors
TMPRSS2 inh.
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19early.org COVID-19 treatment researchNicotineNicotine (more..)
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta
Ivermectin Meta
Thermotherapy Meta
Melatonin Meta
Metformin Meta

 

Nicotine patches in patients on mechanical ventilation for severe COVID-19: a randomized, double-blind, placebo-controlled, multicentre trial

Labro et al., Intensive Care Medicine, doi:10.1007/s00134-022-06721-1, NCT04598594, Jun 2022
https://c19early.org/labro.html
Mortality, day 60 -5% Improvement Relative Risk Mortality, day 28 -2% ECMO -6% Nicotine  Labro et al.  LATE TREATMENT  DB RCT Is late treatment with nicotine beneficial for COVID-19? Double-blind RCT 218 patients in France (November 2020 - April 2021) No significant difference in outcomes seen c19early.org Labro et al., Intensive Care Medicine, Jun 2022 Favorsnicotine Favorscontrol 0 0.5 1 1.5 2+
RCT 218 critically ill COVID-19 patients showing no benefit of transdermal nicotine patches. The trial tested a hypothesis that emerged early in the pandemic based on observations of lower COVID-19 rates among smokers, however alternative explanations such as nitric oxide generation in the respiratory tract may be more likely.
risk of death, 5.3% higher, RR 1.05, p = 0.78, treatment 38 of 101 (37.6%), control 40 of 112 (35.7%), day 60.
risk of death, 2.3% higher, RR 1.02, p = 1.00, treatment 30 of 106 (28.3%), control 31 of 112 (27.7%), day 28.
ECMO, 5.7% higher, RR 1.06, p = 1.00, treatment 14 of 106 (13.2%), control 14 of 112 (12.5%), day 28.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Labro et al., 9 Jun 2022, Double Blind Randomized Controlled Trial, placebo-controlled, France, peer-reviewed, 117 authors, study period 6 November, 2020 - 2 April, 2021, average treatment delay 10.0 days, trial NCT04598594 (history). Contact: alain.combes@aphp.fr (corresponding author).
Nicotine patches in patients on mechanical ventilation for severe COVID-19: a randomized, double-blind, placebo-controlled, multicentre trial
Guylaine Labro, Florence Tubach, Lisa Belin, Jean-Louis Dubost, David Osman, Grégoire Muller, Jean-Pierre Quenot, Daniel Da Silva, Jonathan Zarka, Matthieu Turpin, Julien Mayaux, Christian Lamer, Denis Doyen, Guillaume Chevrel, Gaétan Plantefeve, Sophie Demeret, Gaël Piton, Cyril Manzon, Evelina Ochin, Raphael Gaillard, Bertrand Dautzenberg, Mathieu Baldacini, Said Lebbah, Makoto Miyara, Marc Pineton De Chambrun, Zahir Amoura, Alain Combes, Jessica Palmyre, Linda Gimeno, Assitan Kone, Cedric Vialette, Ouramdane Slimi, Juliette Chommeloux, Lucie Lefevre, Matthieu Schmidt, Guillaume Hekimian, Charles-Edouard Luyt, Laure Stiel, Anne-Florence Dureau, Kuteifan Khaldoun, Hanna Eid, Matthieu Baldacini, Cecile Zyberfajn, Julien Manson, Nathanael Charrier, Angelique Balabanian, Damien Contou, Olivier Pajot, Megan Fraisse, Paul Desaint, Florence Sarfati, Muriel Fartoukh, Guillaume Voirot, Alexandre Elabbabi, Michel Djibre, Cyrielle Desnos, Pierre Garcon, Ly Van Vong, Andrea Issad, Bertrand Pillot, Delphine Reither, Patrick Rouge, Pascale Foliot, Lynda Bendjamar, Valentin Pointurier, Hadrien Winiszewski, Gilles Capellier, Jean-Christophe Navellou, Romain Tapponnier, Emilie Panicucci, Lucas Morand, Jean Dellamonica, Clement Saccheri, Nicolas Weiss, Clemence Marois, Loic Le Guennec, Benjamin Rohaut, Luis Ensenat, Cecilia Billiou, Maria Aroca, Marie Baron, Alexandre Demoule, Alexandra Beurton, Come Bureau, Maxens Decavele, Martin Dres, Frederique Bayle, Quoc Viet Le, Lionel Liron, Jean-Baptiste Putegnat, Francois Salord, Pascal Andreu, Hakim Slimani, Baptiste Roudeau, Marie Labruyere, Marine Jacquier, Nadia Anguel, Soufia Ayed, Edgard Durand, Laurent Guerin, Christopher Lai, Jerome Aboab, Sophie Alviset, Laurent Laine, Mathilde Azzi, Tazime Issoufaly, Laurent Tric, Lyes Knani, Chahrazad Bey Boumezrag, Nicolas Viault, Francois Barbier, Thierry Boulain, Toufik Kamel, Mai-Anh Nay, Sophie Tollec, An Hung Nguyen
Intensive Care Medicine, doi:10.1007/s00134-022-06721-1
Purpose: Epidemiologic studies have documented lower rates of active smokers compared to former or non-smokers in symptomatic patients affected by coronavirus disease 2019 . We assessed the efficacy and safety of nicotine administered by a transdermal patch in critically ill patients with COVID-19 pneumonia. Methods: In this multicentre, double-blind, placebo-controlled trial conducted in 18 intensive care units in France, we randomly assigned adult patients (non-smokers, non-vapers or who had quit smoking/vaping for at least 12 months) with proven COVID-19 pneumonia receiving invasive mechanical ventilation for up to 72 h to receive transdermal patches containing either nicotine at a daily dose of 14 mg or placebo until 48 h following successful weaning from mechanical ventilation or for a maximum of 30 days, followed by 3-week dose tapering by 3.5 mg per week. Randomization was stratified by centre, non-or former smoker status and Sequential Organ Function Assessment score (< or ≥ 7). The primary outcome was day-28 mortality. Main prespecified secondary outcomes included 60-day mortality, time to successful extubation, days alive and free from mechanical ventilation, renal replacement therapy, vasopressor support or organ failure at day 28. Results: Between November 6th 2020, and April 2nd 2021, 220 patients were randomized from 18 active recruiting centers. After excluding 2 patients who withdrew consent, 218 patients (152 [70%] men) were included in the analysis: 106 patients to the nicotine group and 112 to the placebo group. Day-28 mortality did not differ between the two groups (30 [28%] of 106 patients in the nicotine group vs 31 [28%] of 112 patients in the placebo group; odds ratio
Supplementary Information The online version contains supplementary material available at https:// doi. org/ 10. 1007/ s00134-022-06721-1 . Abbreviations Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
Anguel, Leclerc, Soufia Ayed ;, Leclerc, Laurent Guerin ; et al., Service de Médecine Intensive Réanimation du Centre Hospitalier de Saint-Denis, URC-GHT Plaine de France (CHSD-CHG), 2 rue du Dr Delafontaine, 93200 SAINT DENIS. Tazime Issoufaly: Service de Médecine Intensive Réanimation du Centre Hospitalier de Saint-Denis, URC-GHT Plaine de France (CHSD-CHG), 2 rue du
Angus, Derde, Al-Beidh, Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial, JAMA
Bayle, Médipole Lyon Villeurbanne
Beitler, Sarge, Banner-Goodspeed, Effect of titrating positive end-expiratory pressure (PEEP) with an esophageal pressureguided strategy vs an empirical high PEEP-Fio2 strategy on death and days free from mechanical ventilation among patients with acute respiratory distress syndrome: a randomized clinical trial, JAMA
Bendjamar, Eaubonne, Pointurier, Hôpital Simone Veil Eaubonne
Beurton, Groupe Hospitalier Pitié-Salpêtrière Charles Foix, Service de Médecine Intensive et Réanimation (Département R3S)
Buyse, Generalized pairwise comparisons of prioritized outcomes in the two-sample problem, Stat Med
Cecile Zyberfajn, Centre Hospitalier René Dubos PONTOISE
Changeux, Amoura, Rey, A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications, CR Biol
Dautzenberg, Levi, Adler, Transdermal nicotine in nonsmokers: a systematic review to design COVID-19 clinical trials, Respir Med Res
De Jong, Schuppers, Kruisdijk-Gerritsen, The safety and efficacy of nicotine replacement therapy in the intensive care unit: a randomised controlled pilot study, Ann Intensive Care
Decavele, Groupe Hospitalier Pitié-Salpêtrière Charles Foix, Service de Médecine Intensive et Réanimation (Département R3S)
Del Rio, Omer, Malani, Winter of omicron-the evolving COVID-19 pandemic, JAMA
Demoule, Groupe Hospitalier Pitié-Salpêtrière Charles Foix, Service de Médecine Intensive et Réanimation (Département R3S)
Desnos, None
Djibre, None
Dres, Groupe Hospitalier Pitié-Salpêtrière Charles Foix, Service de Médecine Intensive et Réanimation (Département R3S)
Farsalinos, Barbouni, Niaura, Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option?, Intern Emerg Med
Farsalinos, Eliopoulos, Leonidas, Nicotinic cholinergic system and COVID-19: in silico identification of an interaction between SARS-CoV-2 and nicotinic receptors with potential therapeutic targeting implications, Int J Mol Sci
Fine, Gray, A proportional hazards model for the subdistribution of a competing risk, J Am Stat Assoc
Fontanet, Tondeur, Grant, SARS-CoV-2 infection in schools in a northern French city: a retrospective serological cohort study in an area of high transmission, France, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
Fujii, Mashimo, Moriwaki, Expression and function of the cholinergic system in immune cells, Front Immunol
Gall, Lemeshow, Saulnier, A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study, JAMA
Garcon, cours de la Gondoire 77600 Jossigny. Andrea Issad
Ghosh, Girish, Yuan, Combustible and electronic cigarette exposures increase ACE2 activity and SARS-CoV-2 spike binding, Am J Respir Crit Care Med
Gillies, Mckenzie, Whiteley, Safety of nicotine replacement therapy in critically ill smokers: a retrospective cohort study, Intensive Care Med
Gomes, Watad, Shoenfeld, Nicotine and autoimmunity: The lotus' flower in tobacco, Pharmacol Res
Gonzalez-Rubio, Navarro-Lopez, Lopez-Najera, Cytokine release syndrome (CRS) and nicotine in COVID-19 patients: trying to calm the storm, Front Immunol
González-Rubio, Navarro-López, López-Nájera, A systematic review and meta-analysis of hospitalised current smokers and COVID-19, Int J Environ Res Public Health
Gottlieb, Vaca, Paredes, Early remdesivir to prevent progression to severe Covid-19 in outpatients, N Engl J Med
Grasselli, Zangrillo, Zanella, Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy, JAMA
Guan, Ni, Hu, Clinical characteristics of coronavirus disease 2019 in China, N Engl J Med
Hopkinson, Rossi, Moustafa, Current smoking and COVID-19 risk: results from a population symptom app in over 2.4 million people, Thorax
Horby, Lim, Emberson, Dexamethasone in hospitalized patients with Covid-19, N Engl J Med
Ioannou, Locke, Green, Risk factors for hospitalization, mechanical ventilation, or death among 10 131 US veterans with SARS-CoV-2 infection, JAMA Netw Open
Jossigny, Reither, 4 cours de la Gondoire 77600 Jossigny, Grand Hôpital de l'Est Francilien, site de Marne-La-Vallée
Kamiński, Muth, Bogdański, Smoking, vaping, and tobacco industry during COVID-19 pandemic: twitter data analysis, Cyberpsychol Behav Soc Netw
Karagiannidis, Mostert, Hentschker, Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study, Lancet Respir Med
Kavuluru, Noh, Rose, Twitter discourse on nicotine as potential prophylactic or therapeutic for COVID-19, Int J Drug Policy
Lameire, Levin, Kellum, Harmonizing acute and chronic kidney disease definition and classification: report of a kidney disease: improving global outcomes (KDIGO) Consensus Conference, Kidney Int
Lowe, Zein, Hatipoglu, Association of smoking and cumulative pack-year exposure with COVID-19 outcomes in the cleveland clinic COVID-19 registry, JAMA Intern Med
Marois, Médecine Intensive Réanimation à orientation Neurologique
Masso-Silva, Moshensky, Shin, Chronic E-cigarette aerosol inhalation alters the immune state of the lungs and increases ACE2 expression, raising concern for altered response and susceptibility to SARS-CoV-2, Front Physiol
Mazeraud, Jamme, Mancusi, Intravenous immunoglobulins in patients with COVID-19-associated moderate-to-severe acute respiratory distress syndrome (ICAR): multicentre, double-blind, placebo-controlled, phase 3 trial, Lancet Respir Med
Miyara, Tubach, Pourcher, Low rate of daily smokers in patients with symptomatic COVID-19: a monocentric self-report of smoking habit study, Front Med, doi:10.3389/fmed.2021.668995
Navellou, Service de Réanimation Médicale
Oakes, Fuchs, Gardner, Nicotine and the renin-angiotensin system, Am J Physiol Regul Integr Comp Physiol
Paleiron, Mayet, Marbac, Impact of tobacco smoking on the risk of COVID-19: a large scale retrospective cohort study, Nicotine Tobacco Res
Patel, Haar, Handslip, Natural history, trajectory, and management of mechanically ventilated COVID-19 patients in the United Kingdom, Intensive Care Med
Razjouyan, Helmer, Lynch, Smoking status and factors associated with COVID-19 in-hospital mortality among US veterans, Nicotine Tobacco Res
Reddy, Charles, Sklavounos, The effect of smoking on COVID-19 severity: a systematic review and meta-analysis, J Med Virol
Schmidt, Hajage, Lebreton, Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study, Lancet Respir Med
Simons, Shahab, Brown, The association of smoking status with SARS-CoV-2 infection, hospitalization and mortality from COVID-19: a living rapid evidence review with Bayesian meta-analyses (version 7), Addiction
Slimani, None
Thierry Boulain, Service de Médecine Intensive Réanimation
Tizabi, Getachew, Copeland, Nicotine and the nicotinic cholinergic system in COVID-19, FEBS J
Tomchaney, Contoli, Mayo, Paradoxical effects of cigarette smoke and COPD on SARS-CoV-2 infection and disease, BMC Pulm Med
Wang, Yu, Ochani, Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation, Nature
Yan, Zhang, Li, Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2, Science
Yang, Yu, Xu, Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study, Lancet Respir Med
DOI record: { "DOI": "10.1007/s00134-022-06721-1", "ISSN": [ "0342-4642", "1432-1238" ], "URL": "http://dx.doi.org/10.1007/s00134-022-06721-1", "alternative-id": [ "6721" ], "assertion": [ { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "Received", "name": "received", "order": 1, "value": "27 February 2022" }, { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "Accepted", "name": "accepted", "order": 2, "value": "27 April 2022" }, { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "First Online", "name": "first_online", "order": 3, "value": "9 June 2022" }, { "group": { "label": "Declarations", "name": "EthicsHeading" }, "name": "Ethics", "order": 1 }, { "group": { "label": "Conflicts of interest", "name": "EthicsHeading" }, "name": "Ethics", "order": 2, "value": "RG has received compensation as a member of the scientific advisory board of Janssen, Lundbeck, Roche, SOBI, Takeda. He has served as consultant and/or speaker for Astra Zeneca, Boehringer-Ingelheim, Pierre Fabre, Lilly, Lundbeck, LVMH, MAPREG, Novartis, Otsuka, Pileje, SANOFI, Servier and received compensation, and he has received research support from Servier. Co-founder and stock shareholder: Regstem. AC reported receiving grants and personal fees from Maquet, Xenios and Baxter outside the submitted work. No other disclosures were reported." }, { "label": "Free to read", "name": "free", "value": "This content has been made available to all." } ], "author": [ { "affiliation": [], "family": "Labro", "given": "Guylaine", "sequence": "first" }, { "affiliation": [], "family": "Tubach", "given": "Florence", "sequence": "additional" }, { "affiliation": [], "family": "Belin", "given": "Lisa", "sequence": "additional" }, { "affiliation": [], "family": "Dubost", "given": "Jean-Louis", "sequence": "additional" }, { "affiliation": [], "family": "Osman", "given": "David", "sequence": "additional" }, { "affiliation": [], "family": "Muller", "given": "Grégoire", "sequence": "additional" }, { "affiliation": [], "family": "Quenot", "given": "Jean-Pierre", "sequence": "additional" }, { "affiliation": [], "family": "Da Silva", "given": "Daniel", "sequence": "additional" }, { "affiliation": [], "family": "Zarka", "given": "Jonathan", "sequence": "additional" }, { "affiliation": [], "family": "Turpin", "given": "Matthieu", "sequence": "additional" }, { "affiliation": [], "family": "Mayaux", "given": "Julien", "sequence": "additional" }, { "affiliation": [], "family": "Lamer", "given": "Christian", "sequence": "additional" }, { "affiliation": [], "family": "Doyen", "given": "Denis", "sequence": "additional" }, { "affiliation": [], "family": "Chevrel", "given": "Guillaume", "sequence": "additional" }, { "affiliation": [], "family": "Plantefeve", "given": "Gaétan", "sequence": "additional" }, { "affiliation": [], "family": "Demeret", "given": "Sophie", "sequence": "additional" }, { "affiliation": [], "family": "Piton", "given": "Gaël", "sequence": "additional" }, { "affiliation": [], "family": "Manzon", "given": "Cyril", "sequence": "additional" }, { "affiliation": [], "family": "Ochin", "given": "Evelina", "sequence": "additional" }, { "affiliation": [], "family": "Gaillard", "given": "Raphael", "sequence": "additional" }, { "affiliation": [], "family": "Dautzenberg", "given": "Bertrand", "sequence": "additional" }, { "affiliation": [], "family": "Baldacini", "given": "Mathieu", "sequence": "additional" }, { "affiliation": [], "family": "Lebbah", "given": "Said", "sequence": "additional" }, { "affiliation": [], "family": "Miyara", "given": "Makoto", "sequence": "additional" }, { "affiliation": [], "family": "Pineton de Chambrun", "given": "Marc", "sequence": "additional" }, { "affiliation": [], "family": "Amoura", "given": "Zahir", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0002-6030-3957", "affiliation": [], "authenticated-orcid": false, "family": "Combes", "given": "Alain", "sequence": "additional" }, { "affiliation": [], "name": "on behalf of the NICOVID-REA Trial Group", "sequence": "additional" }, { "affiliation": [], "family": "Palmyre", "given": "Jessica", "sequence": "additional" }, { "affiliation": [], "family": "Gimeno", "given": "Linda", "sequence": "additional" }, { "affiliation": [], "family": "Kone", "given": "Assitan", "sequence": "additional" }, { "affiliation": [], "family": "Vialette", "given": "Cedric", "sequence": "additional" }, { "affiliation": [], "family": "Slimi", "given": "Ouramdane", "sequence": "additional" }, { "affiliation": [], "family": "Chommeloux", "given": "Juliette", "sequence": "additional" }, { "affiliation": [], "family": "Lefevre", "given": "Lucie", "sequence": "additional" }, { "affiliation": [], "family": "Schmidt", "given": "Matthieu", "sequence": "additional" }, { "affiliation": [], "family": "Hekimian", "given": "Guillaume", "sequence": "additional" }, { "affiliation": [], "family": "Luyt", "given": "Charles-Edouard", "sequence": "additional" }, { "affiliation": [], "family": "Stiel", "given": "Laure", "sequence": "additional" }, { "affiliation": [], "family": "Dureau", "given": "Anne-Florence", "sequence": "additional" }, { "affiliation": [], "family": "Khaldoun", "given": "Kuteifan", "sequence": "additional" }, { "affiliation": [], "family": "Eid", "given": "Hanna", "sequence": "additional" }, { "affiliation": [], "family": "Baldacini", "given": "Matthieu", "sequence": "additional" }, { "affiliation": [], "family": "Zyberfajn", "given": "Cecile", "sequence": "additional" }, { "affiliation": [], "family": "Manson", "given": "Julien", "sequence": "additional" }, { "affiliation": [], "family": "Charrier", "given": "Nathanael", "sequence": "additional" }, { "affiliation": [], "family": "Balabanian", "given": "Angelique", "sequence": "additional" }, { "affiliation": [], "family": "Contou", "given": "Damien", "sequence": "additional" }, { "affiliation": [], "family": "Pajot", "given": "Olivier", "sequence": "additional" }, { "affiliation": [], "family": "Fraisse", "given": "Megan", "sequence": "additional" }, { "affiliation": [], "family": "Desaint", "given": "Paul", "sequence": "additional" }, { "affiliation": [], "family": "Sarfati", "given": "Florence", "sequence": "additional" }, { "affiliation": [], "family": "Fartoukh", "given": "Muriel", "sequence": "additional" }, { "affiliation": [], "family": "Voirot", "given": "Guillaume", "sequence": "additional" }, { "affiliation": [], "family": "Elabbabi", "given": "Alexandre", "sequence": "additional" }, { "affiliation": [], "family": "Djibre", "given": "Michel", "sequence": "additional" }, { "affiliation": [], "family": "Desnos", "given": "Cyrielle", "sequence": "additional" }, { "affiliation": [], "family": "Garcon", "given": "Pierre", "sequence": "additional" }, { "affiliation": [], "family": "van Vong", "given": "Ly", "sequence": "additional" }, { "affiliation": [], "family": "Issad", "given": "Andrea", "sequence": "additional" }, { "affiliation": [], "family": "Pillot", "given": "Bertrand", "sequence": "additional" }, { "affiliation": [], "family": "Reither", "given": "Delphine", "sequence": "additional" }, { "affiliation": [], "family": "Rouge", "given": "Patrick", "sequence": "additional" }, { "affiliation": [], "family": "Foliot", "given": "Pascale", "sequence": "additional" }, { "affiliation": [], "family": "Bendjamar", "given": "Lynda", "sequence": "additional" }, { "affiliation": [], "family": "Pointurier", "given": "Valentin", "sequence": "additional" }, { "affiliation": [], "family": "Winiszewski", "given": "Hadrien", "sequence": "additional" }, { "affiliation": [], "family": "Capellier", "given": "Gilles", "sequence": "additional" }, { "affiliation": [], "family": "Navellou", "given": "Jean-Christophe", "sequence": "additional" }, { "affiliation": [], "family": "Tapponnier", "given": "Romain", "sequence": "additional" }, { "affiliation": [], "family": "Panicucci", "given": "Emilie", "sequence": "additional" }, { "affiliation": [], "family": "Morand", "given": "Lucas", "sequence": "additional" }, { "affiliation": [], "family": "Dellamonica", "given": "Jean", "sequence": "additional" }, { "affiliation": [], "family": "Saccheri", "given": "Clement", "sequence": "additional" }, { "affiliation": [], "family": "Weiss", "given": "Nicolas", "sequence": "additional" }, { "affiliation": [], "family": "Marois", "given": "Clemence", "sequence": "additional" }, { "affiliation": [], "family": "Le Guennec", "given": "Loic", "sequence": "additional" }, { "affiliation": [], "family": "Rohaut", "given": "Benjamin", "sequence": "additional" }, { "affiliation": [], "family": "Ensenat", "given": "Luis", "sequence": "additional" }, { "affiliation": [], "family": "Billiou", "given": "Cecilia", "sequence": "additional" }, { "affiliation": [], "family": "Aroca", "given": "Maria", "sequence": "additional" }, { "affiliation": [], "family": "Baron", "given": "Marie", "sequence": "additional" }, { "affiliation": [], "family": "Demoule", "given": "Alexandre", "sequence": "additional" }, { "affiliation": [], "family": "Beurton", "given": "Alexandra", "sequence": "additional" }, { "affiliation": [], "family": "Bureau", "given": "Come", "sequence": "additional" }, { "affiliation": [], "family": "Decavele", "given": "Maxens", "sequence": "additional" }, { "affiliation": [], "family": "Dres", "given": "Martin", "sequence": "additional" }, { "affiliation": [], "family": "Bayle", "given": "Frederique", "sequence": "additional" }, { "affiliation": [], "family": "Le", "given": "Quoc Viet", "sequence": "additional" }, { "affiliation": [], "family": "Liron", "given": "Lionel", "sequence": "additional" }, { "affiliation": [], "family": "Putegnat", "given": "Jean-Baptiste", "sequence": "additional" }, { "affiliation": [], "family": "Salord", "given": "Francois", "sequence": "additional" }, { "affiliation": [], "family": "Andreu", "given": "Pascal", "sequence": "additional" }, { "affiliation": [], "family": "Slimani", "given": "Hakim", "sequence": "additional" }, { "affiliation": [], "family": "Roudeau", "given": "Baptiste", "sequence": "additional" }, { "affiliation": [], "family": "Labruyere", "given": "Marie", "sequence": "additional" }, { "affiliation": [], "family": "Jacquier", "given": "Marine", "sequence": "additional" }, { "affiliation": [], "family": "Anguel", "given": "Nadia", "sequence": "additional" }, { "affiliation": [], "family": "Ayed", "given": "Soufia", "sequence": "additional" }, { "affiliation": [], "family": "Durand", "given": "Edgard", "sequence": "additional" }, { "affiliation": [], "family": "Guerin", "given": "Laurent", "sequence": "additional" }, { "affiliation": [], "family": "Lai", "given": "Christopher", "sequence": "additional" }, { "affiliation": [], "family": "Aboab", "given": "Jerome", "sequence": "additional" }, { "affiliation": [], "family": "Alviset", "given": "Sophie", "sequence": "additional" }, { "affiliation": [], "family": "Laine", "given": "Laurent", "sequence": "additional" }, { "affiliation": [], "family": "Azzi", "given": "Mathilde", "sequence": "additional" }, { "affiliation": [], "family": "Issoufaly", "given": "Tazime", "sequence": "additional" }, { "affiliation": [], "family": "Tric", "given": "Laurent", "sequence": "additional" }, { "affiliation": [], "family": "Knani", "given": "Lyes", "sequence": "additional" }, { "affiliation": [], "family": "Boumezrag", "given": "Chahrazad Bey", "sequence": "additional" }, { "affiliation": [], "family": "Viault", "given": "Nicolas", "sequence": "additional" }, { "affiliation": [], "family": "Barbier", "given": "Francois", "sequence": "additional" }, { "affiliation": [], "family": "Boulain", "given": "Thierry", "sequence": "additional" }, { "affiliation": [], "family": "Kamel", "given": "Toufik", "sequence": "additional" }, { "affiliation": [], "family": "Nay", "given": "Mai-Anh", "sequence": "additional" }, { "affiliation": [], "family": "Tollec", "given": "Sophie", "sequence": "additional" }, { "affiliation": [], "family": "Nguyen", "given": "An Hung", "sequence": "additional" } ], "container-title": "Intensive Care Medicine", "container-title-short": "Intensive Care Med", "content-domain": { "crossmark-restriction": false, "domain": [ "link.springer.com" ] }, "created": { "date-parts": [ [ 2022, 6, 9 ] ], "date-time": "2022-06-09T03:33:04Z", "timestamp": 1654745584000 }, "deposited": { "date-parts": [ [ 2024, 9, 26 ] ], "date-time": "2024-09-26T17:47:38Z", "timestamp": 1727372858000 }, "funder": [ { "name": "PHRC" } ], "indexed": { "date-parts": [ [ 2025, 5, 1 ] ], "date-time": "2025-05-01T10:06:05Z", "timestamp": 1746093965416, "version": "3.37.3" }, "is-referenced-by-count": 10, "issue": "7", "issued": { "date-parts": [ [ 2022, 6, 9 ] ] }, "journal-issue": { "issue": "7", "published-print": { "date-parts": [ [ 2022, 7 ] ] } }, "language": "en", "license": [ { "URL": "https://www.springer.com/tdm", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2022, 6, 9 ] ], "date-time": "2022-06-09T00:00:00Z", "timestamp": 1654732800000 } }, { "URL": "https://www.springer.com/tdm", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2022, 6, 9 ] ], "date-time": "2022-06-09T00:00:00Z", "timestamp": 1654732800000 } } ], "link": [ { "URL": "https://link.springer.com/content/pdf/10.1007/s00134-022-06721-1.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://link.springer.com/article/10.1007/s00134-022-06721-1/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://link.springer.com/content/pdf/10.1007/s00134-022-06721-1.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "297", "original-title": [], "page": "876-887", "prefix": "10.1007", "published": { "date-parts": [ [ 2022, 6, 9 ] ] }, "published-online": { "date-parts": [ [ 2022, 6, 9 ] ] }, "published-print": { "date-parts": [ [ 2022, 7 ] ] }, "publisher": "Springer Science and Business Media LLC", "reference": [ { "key": "6721_CR1", "unstructured": "Centers for Disease Control and Prevention: SARS-CoV-2 Variant Classifications and Definitionshttps://www.cdc.gov/coronavirus/2019-ncov/variants/variant-info.html#Concern; Last accessed, January 1st, 2022" }, { "author": "C Del Rio", "first-page": "2", "journal-title": "JAMA", "key": "6721_CR2", "unstructured": "Del Rio C, Omer SB, Malani PN (2021) Winter of omicron-the evolving COVID-19 pandemic. JAMA 2:2", "volume": "2", "year": "2021" }, { "DOI": "10.3389/fmed.2021.668995", "author": "M Miyara", "doi-asserted-by": "publisher", "journal-title": "Front Med", "key": "6721_CR3", "unstructured": "Miyara M, Tubach F, Pourcher V et al (2022) Low rate of daily smokers in patients with symptomatic COVID-19: a monocentric self-report of smoking habit study. Front Med. https://doi.org/10.3389/fmed.2021.668995", "year": "2022" }, { "DOI": "10.1007/s11739-020-02355-7", "author": "K Farsalinos", "doi-asserted-by": "crossref", "first-page": "845", "journal-title": "Intern Emerg Med", "key": "6721_CR4", "unstructured": "Farsalinos K, Barbouni A, Niaura R (2020) Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option? Intern Emerg Med 15:845–852", "volume": "15", "year": "2020" }, { "DOI": "10.1056/NEJMoa2002032", "author": "WJ Guan", "doi-asserted-by": "crossref", "first-page": "1708", "journal-title": "N Engl J Med", "key": "6721_CR5", "unstructured": "Guan WJ, Ni ZY, Hu Y et al (2020) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382:1708–1720", "volume": "382", "year": "2020" }, { "DOI": "10.1111/add.15276", "author": "D Simons", "doi-asserted-by": "crossref", "first-page": "1319", "journal-title": "Addiction (Abingdon, England)", "key": "6721_CR6", "unstructured": "Simons D, Shahab L, Brown J et al (2021) The association of smoking status with SARS-CoV-2 infection, hospitalization and mortality from COVID-19: a living rapid evidence review with Bayesian meta-analyses (version 7). Addiction (Abingdon, England) 116:1319–1368", "volume": "116", "year": "2021" }, { "DOI": "10.2807/1560-7917.ES.2021.26.15.2001695", "doi-asserted-by": "crossref", "key": "6721_CR7", "unstructured": "Fontanet A, Tondeur L, Grant R, et al. (2021) SARS-CoV-2 infection in schools in a northern French city: a retrospective serological cohort study in an area of high transmission, France, January to April 2020. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 26" }, { "DOI": "10.1093/ntr/ntab004", "author": "N Paleiron", "doi-asserted-by": "crossref", "first-page": "1398", "journal-title": "Nicotine Tobacco Res", "key": "6721_CR8", "unstructured": "Paleiron N, Mayet A, Marbac V et al (2021) Impact of tobacco smoking on the risk of COVID-19: a large scale retrospective cohort study. Nicotine Tobacco Res 23:1398–1404", "volume": "23", "year": "2021" }, { "author": "J González-Rubio", "first-page": "2", "journal-title": "Int J Environ Res Public Health", "key": "6721_CR9", "unstructured": "González-Rubio J, Navarro-López C, López-Nájera E et al (2020) A systematic review and meta-analysis of hospitalised current smokers and COVID-19. Int J Environ Res Public Health 17:2", "volume": "17", "year": "2020" }, { "DOI": "10.1002/jmv.26389", "author": "RK Reddy", "doi-asserted-by": "crossref", "first-page": "1045", "journal-title": "J Med Virol", "key": "6721_CR10", "unstructured": "Reddy RK, Charles WN, Sklavounos A et al (2021) The effect of smoking on COVID-19 severity: a systematic review and meta-analysis. J Med Virol 93:1045–1056", "volume": "93", "year": "2021" }, { "DOI": "10.1001/jamainternmed.2020.8360", "author": "KE Lowe", "doi-asserted-by": "crossref", "first-page": "709", "journal-title": "JAMA Intern Med", "key": "6721_CR11", "unstructured": "Lowe KE, Zein J, Hatipoglu U et al (2021) Association of smoking and cumulative pack-year exposure with COVID-19 outcomes in the cleveland clinic COVID-19 registry. JAMA Intern Med 181:709–711", "volume": "181", "year": "2021" }, { "DOI": "10.1126/science.abb2762", "author": "R Yan", "doi-asserted-by": "crossref", "first-page": "1444", "journal-title": "Science", "key": "6721_CR12", "unstructured": "Yan R, Zhang Y, Li Y et al (2020) Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science 367:1444–1448", "volume": "367", "year": "2020" }, { "DOI": "10.1152/ajpregu.00099.2018", "author": "JM Oakes", "doi-asserted-by": "crossref", "first-page": "R895", "journal-title": "Am J Physiol Regul Integr Comp Physiol", "key": "6721_CR13", "unstructured": "Oakes JM, Fuchs RM, Gardner JD et al (2018) Nicotine and the renin-angiotensin system. Am J Physiol Regul Integr Comp Physiol 315:R895-r906", "volume": "315", "year": "2018" }, { "DOI": "10.5802/crbiol.8", "author": "JP Changeux", "doi-asserted-by": "crossref", "first-page": "33", "journal-title": "CR Biol", "key": "6721_CR14", "unstructured": "Changeux JP, Amoura Z, Rey FA et al (2020) A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications. CR Biol 343:33–39", "volume": "343", "year": "2020" }, { "DOI": "10.1111/febs.15521", "author": "Y Tizabi", "doi-asserted-by": "crossref", "first-page": "3656", "journal-title": "FEBS J", "key": "6721_CR15", "unstructured": "Tizabi Y, Getachew B, Copeland RL et al (2020) Nicotine and the nicotinic cholinergic system in COVID-19. FEBS J 287:3656–3663", "volume": "287", "year": "2020" }, { "author": "B Dautzenberg", "journal-title": "Respir Med Res", "key": "6721_CR16", "unstructured": "Dautzenberg B, Levi A, Adler M et al (2021) Transdermal nicotine in non-smokers: a systematic review to design COVID-19 clinical trials. Respir Med Res 80:100844", "volume": "80", "year": "2021" }, { "DOI": "10.1038/nature01339", "author": "H Wang", "doi-asserted-by": "crossref", "first-page": "384", "journal-title": "Nature", "key": "6721_CR17", "unstructured": "Wang H, Yu M, Ochani M et al (2003) Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 421:384–388", "volume": "421", "year": "2003" }, { "DOI": "10.3389/fimmu.2017.01085", "author": "T Fujii", "doi-asserted-by": "crossref", "first-page": "1085", "journal-title": "Front Immunol", "key": "6721_CR18", "unstructured": "Fujii T, Mashimo M, Moriwaki Y et al (2017) Expression and function of the cholinergic system in immune cells. Front Immunol 8:1085", "volume": "8", "year": "2017" }, { "DOI": "10.3390/ijms21165807", "author": "K Farsalinos", "doi-asserted-by": "crossref", "first-page": "2", "journal-title": "Int J Mol Sci", "key": "6721_CR19", "unstructured": "Farsalinos K, Eliopoulos E, Leonidas DD et al (2020) Nicotinic cholinergic system and COVID-19: in silico identification of an interaction between SARS-CoV-2 and nicotinic receptors with potential therapeutic targeting implications. Int J Mol Sci 21:2", "volume": "21", "year": "2020" }, { "DOI": "10.3389/fimmu.2020.01359", "author": "J Gonzalez-Rubio", "doi-asserted-by": "crossref", "first-page": "1359", "journal-title": "Front Immunol", "key": "6721_CR20", "unstructured": "Gonzalez-Rubio J, Navarro-Lopez C, Lopez-Najera E et al (2020) Cytokine release syndrome (CRS) and nicotine in COVID-19 patients: trying to calm the storm. Front Immunol 11:1359", "volume": "11", "year": "2020" }, { "DOI": "10.1016/j.phrs.2017.10.005", "author": "JP Gomes", "doi-asserted-by": "crossref", "first-page": "101", "journal-title": "Pharmacol Res", "key": "6721_CR21", "unstructured": "Gomes JP, Watad A, Shoenfeld Y (2018) Nicotine and autoimmunity: The lotus’ flower in tobacco. Pharmacol Res 128:101–109", "volume": "128", "year": "2018" }, { "DOI": "10.1001/jama.1993.03510240069035", "author": "JR Le Gall", "doi-asserted-by": "crossref", "first-page": "2957", "journal-title": "JAMA", "key": "6721_CR22", "unstructured": "Le Gall JR, Lemeshow S, Saulnier F (1993) A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957–2963", "volume": "270", "year": "1993" }, { "author": "N Lameire", "first-page": "2", "journal-title": "Kidney Int", "key": "6721_CR23", "unstructured": "Lameire N, Levin A, Kellum JA et al (2021) Harmonizing acute and chronic kidney disease definition and classification: report of a kidney disease: improving global outcomes (KDIGO) Consensus Conference. Kidney Int 2:2", "volume": "2", "year": "2021" }, { "key": "6721_CR24", "unstructured": "Base documentaire de l'APHP sur la COVID-19: http://covid-documentation.aphp.fr/; Last accessed, January 1st 2022" }, { "key": "6721_CR25", "unstructured": "IDSA Guidelines on the Treatment and Management of Patients with COVID-19: https://www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management/; Last accessed, January 11st 2022" }, { "DOI": "10.1001/jama.2019.0555", "author": "JR Beitler", "doi-asserted-by": "crossref", "first-page": "846", "journal-title": "JAMA", "key": "6721_CR26", "unstructured": "Beitler JR, Sarge T, Banner-Goodspeed VM et al (2019) Effect of titrating positive end-expiratory pressure (PEEP) with an esophageal pressure-guided strategy vs an empirical high PEEP-Fio2 strategy on death and days free from mechanical ventilation among patients with acute respiratory distress syndrome: a randomized clinical trial. JAMA 321:846–857", "volume": "321", "year": "2019" }, { "DOI": "10.1007/s00134-020-06294-x", "doi-asserted-by": "crossref", "key": "6721_CR27", "unstructured": "(2021) COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators, Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study. Intensive Care Med 47: 60–73" }, { "DOI": "10.1001/jama.2020.5394", "author": "G Grasselli", "doi-asserted-by": "crossref", "first-page": "1574", "journal-title": "JAMA", "key": "6721_CR28", "unstructured": "Grasselli G, Zangrillo A, Zanella A et al (2020) Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA 323:1574–1581", "volume": "323", "year": "2020" }, { "DOI": "10.1080/01621459.1999.10474144", "author": "JP Fine", "doi-asserted-by": "crossref", "first-page": "496", "journal-title": "J Am Stat Assoc", "key": "6721_CR29", "unstructured": "Fine JP, Gray RJ (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496–509", "volume": "94", "year": "1999" }, { "DOI": "10.1002/sim.3923", "author": "M Buyse", "doi-asserted-by": "crossref", "first-page": "3245", "journal-title": "Stat Med", "key": "6721_CR30", "unstructured": "Buyse M (2010) Generalized pairwise comparisons of prioritized outcomes in the two-sample problem. Stat Med 29:3245–3257", "volume": "29", "year": "2010" }, { "DOI": "10.1089/cyber.2020.0384", "author": "M Kamiński", "doi-asserted-by": "crossref", "first-page": "811", "journal-title": "Cyberpsychol Behav Soc Netw", "key": "6721_CR31", "unstructured": "Kamiński M, Muth A, Bogdański P (2020) Smoking, vaping, and tobacco industry during COVID-19 pandemic: twitter data analysis. Cyberpsychol Behav Soc Netw 23:811–817", "volume": "23", "year": "2020" }, { "author": "R Kavuluru", "journal-title": "Int J Drug Policy", "key": "6721_CR32", "unstructured": "Kavuluru R, Noh J, Rose SW (2021) Twitter discourse on nicotine as potential prophylactic or therapeutic for COVID-19. Int J Drug Policy 99:103470", "volume": "99", "year": "2021" }, { "author": "A Ghosh", "first-page": "2", "journal-title": "Am J Respir Crit Care Med", "key": "6721_CR33", "unstructured": "Ghosh A, Girish V, Yuan ML et al (2021) Combustible and electronic cigarette exposures increase ACE2 activity and SARS-CoV-2 spike binding. Am J Respir Crit Care Med 2:2", "volume": "2", "year": "2021" }, { "author": "JA Masso-Silva", "journal-title": "Front Physiol", "key": "6721_CR34", "unstructured": "Masso-Silva JA, Moshensky A, Shin J et al (2021) Chronic E-cigarette aerosol inhalation alters the immune state of the lungs and increases ACE2 expression, raising concern for altered response and susceptibility to SARS-CoV-2. Front Physiol 12:649604", "volume": "12", "year": "2021" }, { "DOI": "10.1186/s12890-021-01639-8", "author": "M Tomchaney", "doi-asserted-by": "crossref", "first-page": "275", "journal-title": "BMC Pulm Med", "key": "6721_CR35", "unstructured": "Tomchaney M, Contoli M, Mayo J et al (2021) Paradoxical effects of cigarette smoke and COPD on SARS-CoV-2 infection and disease. BMC Pulm Med 21:275", "volume": "21", "year": "2021" }, { "DOI": "10.1136/thoraxjnl-2020-216422", "author": "NS Hopkinson", "doi-asserted-by": "crossref", "first-page": "714", "journal-title": "Thorax", "key": "6721_CR36", "unstructured": "Hopkinson NS, Rossi N, El-Sayed Moustafa J et al (2021) Current smoking and COVID-19 risk: results from a population symptom app in over 2.4 million people. Thorax 76:714–722", "volume": "76", "year": "2021" }, { "author": "GN Ioannou", "journal-title": "JAMA Netw Open", "key": "6721_CR37", "unstructured": "Ioannou GN, Locke E, Green P et al (2020) Risk factors for hospitalization, mechanical ventilation, or death among 10 131 US veterans with SARS-CoV-2 infection. JAMA Netw Open 3:e2022310", "volume": "3", "year": "2020" }, { "author": "J Razjouyan", "first-page": "2", "journal-title": "Nicotine Tobacco Res", "key": "6721_CR38", "unstructured": "Razjouyan J, Helmer DA, Lynch KE et al (2021) Smoking status and factors associated with COVID-19 in-hospital mortality among US veterans. Nicotine Tobacco Res 2:2", "volume": "2", "year": "2021" }, { "DOI": "10.1016/S2213-2600(21)00440-9", "doi-asserted-by": "crossref", "key": "6721_CR39", "unstructured": "Mazeraud A, Jamme M, Mancusi RL, et al., (2021) Intravenous immunoglobulins in patients with COVID-19-associated moderate-to-severe acute respiratory distress syndrome (ICAR): multicentre, double-blind, placebo-controlled, phase 3 trial. Lancet Respir Med" }, { "DOI": "10.1016/S2213-2600(20)30316-7", "author": "C Karagiannidis", "doi-asserted-by": "crossref", "first-page": "853", "journal-title": "Lancet Respir Med", "key": "6721_CR40", "unstructured": "Karagiannidis C, Mostert C, Hentschker C et al (2020) Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study. Lancet Respir Med 8:853–862", "volume": "8", "year": "2020" }, { "DOI": "10.1007/s00134-021-06389-z", "author": "BV Patel", "doi-asserted-by": "crossref", "first-page": "549", "journal-title": "Intensive Care Med", "key": "6721_CR41", "unstructured": "Patel BV, Haar S, Handslip R et al (2021) Natural history, trajectory, and management of mechanically ventilated COVID-19 patients in the United Kingdom. Intensive Care Med 47:549–565", "volume": "47", "year": "2021" }, { "DOI": "10.1016/S2213-2600(20)30328-3", "author": "M Schmidt", "doi-asserted-by": "crossref", "first-page": "1121", "journal-title": "Lancet Respir Med", "key": "6721_CR42", "unstructured": "Schmidt M, Hajage D, Lebreton G et al (2020) Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study. Lancet Respir Med 8:1121–1131", "volume": "8", "year": "2020" }, { "DOI": "10.1016/S2213-2600(20)30079-5", "author": "X Yang", "doi-asserted-by": "crossref", "first-page": "475", "journal-title": "Lancet Respir Med", "key": "6721_CR43", "unstructured": "Yang X, Yu Y, Xu J et al (2020) Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 8:475–481", "volume": "8", "year": "2020" }, { "DOI": "10.1186/s13613-018-0399-1", "author": "B de Jong", "doi-asserted-by": "crossref", "first-page": "70", "journal-title": "Ann Intensive Care", "key": "6721_CR44", "unstructured": "de Jong B, Schuppers AS, Kruisdijk-Gerritsen A et al (2018) The safety and efficacy of nicotine replacement therapy in the intensive care unit: a randomised controlled pilot study. Ann Intensive Care 8:70", "volume": "8", "year": "2018" }, { "author": "RL Gottlieb", "first-page": "2", "journal-title": "N Engl J Med", "key": "6721_CR45", "unstructured": "Gottlieb RL, Vaca CE, Paredes R et al (2021) Early remdesivir to prevent progression to severe Covid-19 in outpatients. N Engl J Med 2:2", "volume": "2", "year": "2021" }, { "DOI": "10.1007/s00134-012-2604-2", "author": "MA Gillies", "doi-asserted-by": "crossref", "first-page": "1683", "journal-title": "Intensive Care Med", "key": "6721_CR46", "unstructured": "Gillies MA, McKenzie CA, Whiteley C et al (2012) Safety of nicotine replacement therapy in critically ill smokers: a retrospective cohort study. Intensive Care Med 38:1683–1688", "volume": "38", "year": "2012" }, { "DOI": "10.1001/jama.2020.17022", "author": "DC Angus", "doi-asserted-by": "crossref", "first-page": "1317", "journal-title": "JAMA", "key": "6721_CR47", "unstructured": "Angus DC, Derde L, Al-Beidh F et al (2020) Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial. JAMA 324:1317–1329", "volume": "324", "year": "2020" }, { "DOI": "10.1056/NEJMoa2021436", "author": "P Horby", "doi-asserted-by": "crossref", "first-page": "693", "journal-title": "N Engl J Med", "key": "6721_CR48", "unstructured": "Horby P, Lim WS, Emberson JR et al (2021) Dexamethasone in hospitalized patients with Covid-19. N Engl J Med 384:693–704", "volume": "384", "year": "2021" } ], "reference-count": 48, "references-count": 48, "relation": {}, "resource": { "primary": { "URL": "https://link.springer.com/10.1007/s00134-022-06721-1" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Nicotine patches in patients on mechanical ventilation for severe COVID-19: a randomized, double-blind, placebo-controlled, multicentre trial", "type": "journal-article", "update-policy": "https://doi.org/10.1007/springer_crossmark_policy", "volume": "48" }
Late treatment
is less effective
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. IMA and WCH provide treatment protocols.
  or use drag and drop   
Submit